Know Cancer

forgot password

Benign Hysterectomy; a Randomized Controlled Trial Comparing Robotic Hysterectomy With Vaginal Hysterectomy and Traditional Laparoscopic Hysterectomy

25 Years
Open (Enrolling)
Menorrhagia, Metrorrhagia, Uterine Fibroids, Cervical Dysplasia

Thank you

Trial Information

Benign Hysterectomy; a Randomized Controlled Trial Comparing Robotic Hysterectomy With Vaginal Hysterectomy and Traditional Laparoscopic Hysterectomy

Laparoscopic surgery is advantageous compared to open surgery in terms of patient morbidity,
shorter hospitalization and a more rapid return to daily activities. Robot-assisted
laparoscopic surgery have facilitated a higher proportion of minimally invasive surgery
first and foremost within gynecologic oncology.It is not clear whether or not this is true
for less advanced surgery where a vaginal approach or a traditional laparoscopic approach is

Robot-assisted surgery is associated with additional cost due to investment and more
expensive surgical equipment. The study is performed to investigate whether or not
performing hysterectomy for benign conditions with robotic surgery will be advantageous in
terms of shorter operating time, less complications, less conversions to open surgery, and
shorter hospital stay in comparison to other minimally invasive procedures such as vaginal
hysterectomy and traditional laparoscopic hysterectomy.

Inclusion Criteria:

- indication for hysterectomy for benign disease or prophylactic surgery due to
hereditary cancer

- size of uterus and vagina allows for retrieval by the vaginal route

- maximum uterine size equivalent to 16 weeks of pregnancy

- informed consent

Exclusion Criteria:

- malignant disease

- known extensive intra-abdominal adhesions

- anaesthesiological contraindications to laparoscopic surgery

- women with pacemaker or other implants where electrosurgery is to be avoided

- immunoincompetent women

- simultaneous need for prolapse surgery

- women with known defects of the hemostasis

- allergies towards metronidazole and doxycycline

- inability to understand patient information

Type of Study:


Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Cost of surgery

Outcome Description:

The cost of surgery includes the actual surgery (anaesthesia, OR-nurse, circulating nurse, doctors and use of the OR) as well as the length of the inpatient stay. The cost for conversions to open surgery, reoperations, readmissions, and any additional cost associated with additional procedures or medical interventions such as radiological examinations and blood transfusions. Based on the estimated cost of surgical material, use of the operating room and cost of anaesthesia each benign hysterectomy performed with robotic surgery would need to be 50 minutes shorter than other minimal invasive procedures to compensate for the additional cost.

Outcome Time Frame:

4 months

Safety Issue:


Principal Investigator

Jan Persson, MD, PhD

Investigator Role:

Study Director

Investigator Affiliation:

Department of Obstetrics and Gynecology, Skane University Hospital, Lund


Sweden: Institutional Review Board

Study ID:




Start Date:

January 2010

Completion Date:

December 2015

Related Keywords:

  • Menorrhagia
  • Metrorrhagia
  • Uterine Fibroids
  • Cervical Dysplasia
  • Uterine Cervical Dysplasia
  • Cervical Intraepithelial Neoplasia
  • Leiomyoma
  • Menorrhagia
  • Metrorrhagia
  • Myofibroma